NATCO PHARMA
Back to Cashflow Statement
|
NATCO PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-16 Cr | ₹72 Cr | ₹-68 Cr | ₹9.00 Cr | ₹76 Cr |
What is the latest Net Cash Inflow / Outflow ratio of NATCO PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-16 Cr |
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹-68 Cr |
| Mar2023 | ₹9.00 Cr |
| Mar2022 | ₹76 Cr |
How is Net Cash Inflow / Outflow of NATCO PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-16 Cr | Negative | |
| Mar2025 | ₹72 Cr | Positive | |
| Mar2024 | ₹-68 Cr | Negative | |
| Mar2023 | ₹9.00 Cr | -88.16 | |
| Mar2022 | ₹76 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,579.3 Cr | 1.2% | -4.9% | -4.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | 1.2% |
-4.9% |
-4.5% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses